Timpad, Jenita L.

HRN: 26-21-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2025
CEFTRIAXONE 1G (VIAL)
08/06/2025
08/12/2025
IVTT
2g
OD
Cap-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: